GlassScriptPhysician profile
Bill M Park
NPI 1912902115
$5,392.02
in general payments reported to CMS, 2019-2025
19 companies · $618 in 2025
The $618 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $205 · 2021: $486 · 2022: $1,391 · 2023: $720 · 2024: $1,080 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,417.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,034.20 | 2019-2024 | Acuvue |
| Alcon Vision LLC | $918.85 | 2019-2025 | Precision 1, Dailies Total1, Precision 7 |
| Coopervision INC. | $904.66 | 2019-2025 | Myday Contact Lens, Onefit Contact Lens |
| Oyster Point Pharma, INC. | $584.41 | 2022-2024 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $475.16 | 2022-2025 | Miebo, Xiidra, Infuse |
| Glaukos Corporation | $279.54 | 2022-2025 | Photrexa Viscous and Photrexa, Idosetr |
| Sight Sciences, INC. | $269.54 | 2021-2024 | Tearcare System |
| Sun Pharmaceutical Industries INC. | $201.01 | 2020-2025 | |
| Shire North American Group INC | $169.42 | 2019 | |
| Abbvie INC. | $134.23 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $122.29 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $103.84 | 2019-2022 | |
| Ivantis, INC | $35.91 | 2021 | |
| Carl Zeiss Meditec, INC. | $35.58 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.21 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $27.83 | 2022 | |
| Allergan, INC. | $23.13 | 2021 | |
| Kala Pharmaceuticals, INC. | $21.46 | 2021 | |
| Iridex Corporation | $20.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bill Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.